Ventilator-Associated Events (VAEs): A Patient Safety Opportunity
Join atom Alliance and Dr. Michael Klompas, Associate Professor at Harvard Medical School, to learn about the opportunity to improve patient safety for VAEs.
According to Dr. Klompas, quality improvement programs have traditionally used ventilator-associated pneumonia (VAP) rates to measure quality of care for ventilated patients on the rationale that VAP is common, morbid and preventable. VAP surveillance, however, has significant limitations that compromise its utility for quality improvement programs.
To address some of these limitations, the Centers for Disease Control and Prevention (CDC) and its partners created a surveillance paradigm for ventilated patients called ventilator-associated events (VAEs). VAE definitions were designed to broaden the scope of surveillance and to make surveillance more objective.
What we’ll cover:
During this free webinar, Dr. Klompas will
review the rationale for the CDC’s new surveillance paradigm,
summarize the evidence base for the new definitions,
explore emerging strategies for prevention and
consider the potential benefits of VAE surveillance for hospital safety programs.
Who should attend:
Hospital Infection Preventionists
Epidemiologists
ICU Physicians
Quality Improvement Departments
Safety Officers
Speaker Bio:
Dr. Michael Klompas is an Associate Professor at Harvard Medical School and Associate Hospital Epidemiologist at Brigham and Women’s Hospital in Boston. He attends on the infectious disease and internal medicine services of Brigham and Women’s Hospital. Dr. Klompas has published widely on surveillance, diagnosis, prevention, and treatment of ventilator-associated pneumonia.
